Calluna Pharma launches and announces EUR 75 million Series A financing to develop novel therapies for inflammatory and fibrotic diseases
· Clinical stage company formed from the merger of Oxitope Pharma and Arxx Therapeutics · Calluna Pharma has a pipeline of selective antibodies targeting immunological diseases
New NHS blood group genotyping test developed with BioResource launches today
From today, almost 18,000 people in England with sickle cell disorder and thalassaemia can have a world-first genetic test to better match future blood transfusions, reducing the risk of side effects.
Seeking managers for research interviews on workplace wellbeing decisions
The UEA workplace wellbeing team calls for UK managers of any level, any sector, to take part in new research about decision-making on workplace wellbeing activities.
ERS Genomics and StemSight sign CRISPR/Cas9 license agreement
License agreement provides StemSight access to CRISPR/Cas9 technology to be applied in development of cell therapies for corneal blindnessDublin, Ireland, and Tampere, Finland - ERS Genomics Limited (‘ERS’), the CRISPR licensing Company,
The emerging business models for digital therapeutics
This article was originally published at Med Device Online.
Guardtech pledge to support NHS aseptic pharmacy units in 2024 after spike in enquiries
The Haverhill cleanroom construction experts have been inundated with enquiries from the nation’s healthcare heroes in recent months
Supporting a Phase III R&D strategy within the anti-infective space
Client Issue An emerging pharmaceutical company sought to evaluate Phase III development strategies for an anti-infective drug with potential to treat a range of patient populations.
A complimentary Cost-Savings Audit Breathe Technology
Breathe Technology is currently providing a free, cost-savings audit. A friendly, no-obligation and knowledgeable service.
Establishing real-world testing and treatment patterns for EGFR NSCLC patients
Client issue Oncology-focused biotech was looking to establish real-world testing and treatment patterns among EGFR NSCLC patients in US, EU, Japan, and Greater China (mainland, HK, and Taiwan).
Rare Disease: 2023 in Review
As we look back at another busy year for the rare disease (RD) space, we also reflect on the continued growth of CRA’s rare disease capabilities and offerings.
How to start your health journey: key health skills for success
Creative Nutritionist writes...Happy New Year everyone! I hope you had a lovely Christmas break.
If you are starting your health journey this January, and you are a bit confused as to what to do- don’t worry! I have you covered.
Prism facilitate sale of Cambridge-based medtech design consultancy
Prism Corporate Broking are pleased to announce that we have facilitated the sale of medtech device design and development consultancy, Springboard Pro Ltd, to leading global healthcare packaging and medical device manufacturers, Sanner GmbH (Sanner Group), a company backed by Europe’s leading healthcare specialist private equity investor, GHO Capital.
Cellular Origins, a TTP Company, establishes Advisory Board of global industry leaders
Renowned experts from across the CGT and robotics industries, Professor John Campbell, Dr Matthew Li, Dr Paul Roberts, and Geoffrey Hodge appointed to provide strategic and technical perspectives
Corazon Health has been re-accredited by the Good Business Charter
Corazon Health has been re-accredited by the Good Business Charter in recognition of responsible business practices.
Evolving business models: Pharmaceutical incubators
As pharmaceutical manufacturers grow, they often pursue external sources of innovation to supplement their own R&D efforts.
AI in drug discovery and development: Will it live up to the hype?
The recent explosion of generative artificial intelligence (AI) has fueled interest in and concern over the use of AI in drug discovery and research and development.
Cuttsy+Cuttsy appoints Harriet Karia as Managing Director
Cambridge, UK — January 2024 — Cuttsy+Cuttsy, a healthcare communication agency, is pleased to announce the appointment of Harriet Karia as its first Managing Director. This move follows a period of substantial growth and is a practical step towards the agency's future plans.
Love Your Liver Awareness Month
Love Your Liver Awareness Month is a campaign run by the British Liver Trust devoted to liver health aiming to put a spotlight on the risk factors of liver disease and the steps people can take to look after their liver.
BioResource-supported study finds ongoing brain injury caused by COVID-19 may not always be detected by routine tests
A new study published in Nature Communications details that markers of brain injury are present in the blood many months after COVID-19 infection, despite inflammation blood tests being normal.
Sanner Group strengthens medical device design and development capabilities with the acquisition of Springboard Pro
Sanner Group, a leading global healthcare packaging manufacturer and medical device Contract Development and Manufacturing Organisation (CDMO) has acquired Springboard, a specialist in the design and development of medical devices for regulated markets.
Arecor appoints Dr Helen Parris as Senior Vice President, Commercial And General Manager of Tetris Pharma Ltd
Cambridge, UK - Arecor Therapeutics plc, the biopharmaceutical company advancing today’s therapies to enable healthier lives, is pleased to announce the appointment of Dr. Helen Parris as Senior Vice President, Commercial and General Manager of the Group’s subsidiary company, Tetris Pharma Ltd ("Tetris Pharma”), effective Monday 15 January 2024.
Senior NHS Trust staff amongst first recruits to join new BioResource Centre in Sheffield at launch event
More than 250,000 volunteers across England have already signed up to the national NIHR BioResource, with the new Sheffield BioResource Centre aiming to recruit 800 people a year.
Top tips for presenters: What are your feet saying?!
Presentation Coaching writes...You’ve prepared and rehearsed your presentation, you’ve thought about how to make your audience feel welcome and keep them engaged - you’ve done all the hard work. But does your body language undermine you when you get on stage? In today’s blog, we consider what our hips, legs and feet may be saying about us.